SV Life Sciences
Investor profile
Investment firm
SV Life Sciences has backed 4 European tech companies across 4 funding rounds between 2011 and 2017, joining rounds totalling €95M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
4
distinct rounds
Companies
4
backed
Active span
2011–2017
7 yrs
Total round €
€95M
sum of rounds joined
Deals by year
distinct rounds / yearSV Life Sciences — deals by year — interactive chart.
Data table
| SV Life Sciences — deals by year | |
|---|---|
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
Top sectors
by dealsSV Life Sciences — top sectors — interactive chart.
Data table
| SV Life Sciences — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsSV Life Sciences — stages — interactive chart.
Data table
| SV Life Sciences — stages | |
|---|---|
| Series A | 2 |
| Series B | 1 |
| Other | 1 |
Countries
by dealsSV Life Sciences — countries — interactive chart.
Data table
| SV Life Sciences — countries | |
|---|---|
| UK | 4 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Artios | UK | 1 | €29M |
| Pulmocide | UK | 1 | €28M |
| Kesios Therapeutics | UK | 1 | €27M |
| Imperial Innovations Limited | UK | 1 | €11M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Artios | Series A | €29M | 2016-09 |
| Pulmocide | Series B | €28M | 2017-03 |
| Kesios Therapeutics | Series A | €27M | 2015-12 |
| Imperial Innovations Limited | Other | €11M | 2011-12 |